Pinnacle Bancorp’s Adaptive Biotechnologies ADPT Stock Holding History

Pinnacle Bancorp’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.6K	Hold	772	–	–	﹤0.01%	662
2026 Q1	$10.7K	Hold	772	–	–	﹤0.01%	700
2025 Q4	$12.5K	Hold	772	–	–	﹤0.01%	660
2025 Q3	$11.5K	Hold	772	–	–	﹤0.01%	708
2025 Q2	$8.99K	Hold	772	–	–	﹤0.01%	732
2025 Q1	$5.74K	Hold	772	–	–	﹤0.01%	762
2024 Q4	$4.63K	Hold	772	–	–	﹤0.01%	793
2024 Q3	$3.95K	Hold	772	–	–	﹤0.01%	810
2024 Q2	$2.79K	Hold	772	–	–	﹤0.01%	800
2024 Q1	$2.48K	Hold	772	–	–	﹤0.01%	795
2023 Q4	$3.78K	Hold	772	–	–	﹤0.01%	739
2023 Q3	$4.21K	Hold	772	–	–	﹤0.01%	709
2023 Q2	$5.18K	Hold	772	–	–	﹤0.01%	676
2023 Q1	$6.82K	Buy	+772	New	+$6.81K	﹤0.01%	671

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Pinnacle Bancorp's ADPT Position: Q2 2026 in Review

Pinnacle Bancorp held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 772 shares worth $16.6K. The position accounts for ﹤0.01% of the portfolio, ranked #662.

Pinnacle Bancorp first reported a position in ADPT in Q1 2023 and has held it in 14 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

Pinnacle Bancorp held 772 shares of Adaptive Biotechnologies worth $16.6K as of Q2 2026.
Pinnacle Bancorp left its Adaptive Biotechnologies share count unchanged in Q2 2026.
Adaptive Biotechnologies made up ﹤0.01% of Pinnacle Bancorp's portfolio in Q2 2026, its #662 holding.
Pinnacle Bancorp first reported a position in Adaptive Biotechnologies in Q1 2023 and has held it in 14 quarters since.
300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Pinnacle Bancorp's 13F filing for Q2 2026, filed 28 Jul 2026.